Alvarez, L., & Whittemore, J. (2009). Liver enzyme elevations in dogs: Diagnostic approach. Compendium: Continuing Education for Veterinarians, 31(9), 416–418.

Assawarachan, S. N., Chuchalermporn, P., Maneesaay, P., & Thengchaisri, N. (2019). Evaluation of hepatobiliary ultrasound scores in healthy dogs and dogs with liver diseases. Veterinary World, 12(8), 1266–1272.

Assawarachan, S. N., Maneesaay, P., & Thengchaisri, N. A. (2020). Descriptive study of the histopathologic and biochemical liver test abnormalities in dogs with liver disease in Thailand. Canadian Journal of Veterinary Research, 84(3), 217–224.

Assawarachan, S. N., Ongvisespaibool, T., Hakhen, B., Chuchalermporn, P., Maneesaay, P., & Thengchaisri, N. (2023). Predictive factors for two-year survival in dogs with hepatobiliary diseases: Importance of clinical and laboratory monitoring. Animals, 13(16), 2677.

Bellafante, D., Gioia, S., Faccioli, J., Riggio, O., Ridola, L., & Nardelli, S. (2024). The management of hepatic encephalopathy from ward to domiciliary care: Current evidence and gray areas. Journal of Clinical Medicine, 13(1), 166.

Besa, C., Cruz, J. P., Huete, A., & Cruz, F. (2012). Portal biliopathy: A multitechnique imaging approach. Abdominal Imaging, 37, 83–90.

Caporali, E. H. G., Phillips, H., Underwood, L., & Selmic, L. E. (2015). Risk factors for urolithiasis in dogs with congenital extrahepatic portosystemic shunts: 95 cases (1999–2013). Journal of the American Veterinary Medical Association, 246, 530–536.

Chapman, S. E., & Hostutler, R. A. (2013). A laboratory diagnostic approach to hepatobiliary disease in small animals. Veterinary Clinics of North America: Small Animal Practice, 43, 1209–1225.

Cheon, S. Y., Jo, D., Kim, Y. K., & Song, J. (2022). Long noncoding RNAs regulate hyperammonemia-induced neuronal damage in hepatic encephalopathy. Oxidative Medicine and Cellular Longevity, 2022, 7628522.

Elhiblu, M. A., Dua, K., Mohindroo, J., Mahajan, S. K., Sood, N. K., & Dhaliwal, P. S. (2015). Clinico-hemato-biochemical profile of dogs with liver cirrhosis. Veterinary World, 8, 487–491.

European Association for the Study of the Liver (2022). EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. Journal of Hepatology, 77(3), 807–824.

Farhoodimoghadam, M., Reagan, K. L., & Zwingenberger, A. L. (2024). Diagnosis and classification of portosystemic shunts: A machine learning retrospective case-control study. Frontiers in Veterinary Science, 11, 1291318.

Ferenci, P. (2017). Hepatic encephalopathy. Gastroenterology Report, 5(2), 138–147.

Gluud, L. L., Vilstrup, H., & Morgan, M. Y. (2016). Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis. Hepatology, 64, 908–922.

Gow, A. G. (2017). Hepatic encephalopathy. Veterinary Clinics of North America: Small Animal Practice, 47(3), 585–599.

Hadjihambi, A., Harrison, I. F., Costas-Rodríguez, M., Vanhaecke, F., Arias, N., Gallego-Durán, R., Mastitskaya, S., Hosford, P. S., Olde Damink, S. W. M., Davies, N., Habtesion, A., Lythgoe, M. F., Gourine, A. V., & Jalan, R. (2019). Impaired brain glymphatic flow in experimental hepatic encephalopathy. Journal of Hepatology, 70(1), 40–49.

Jalan, R., Shawcross, D., & Davies, N. (2003). The molecular pathogenesis of hepatic encephalopathy. The International Journal of Biochemistry and Cell Biology, 35(8), 1175–1181.

Jawaro, T., Yang, A., Dixit, D., & Bridgeman, M. B. (2016). Management of hepatic encephalopathy: A primer. Annals of Pharmacotherapy, 50(7), 569–577.

Kabaria, S., Dalal, I., Gupta, K., Bhurwal, A., Minacapelli, C. D., Catalano, C., & Rustgi, V. (2021). Hepatic encephalopathy. Hepatology, 9(1), 89–97.

Kashliak, N. O., & Vlizlo, V. V. (2023). Symptomy, biokhimichni pokaznyky ta zahal’nyj analiz krovi za hepatopatiji u sobak [Symptoms, biochemical indicators and general blood analysis for hepatopathy in dogs]. Scientific Messenger of Lviv National University of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences, 112, 193–200 (in Ukrainian).

Kawaguchi, T., Suzuki, F., Imamura, M., Murashima, N., Yanase, M., Mine, T., Fujisawa, M., Sato, I., Yoshiji, H., Okita, K., & Suzuki, K. (2019). Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials. Hepatology Research, 49(4), 404–418.

Kilpatrick, S., Gow, A. G., Foale, R. D., Tappin, S. W., Carruthers, H., Reed, N., Yool, D. A., Woods, S., Marques, A. I., Jalan, R., Mellanby, R. J. (2014). Plasma cytokine concentrations in dogs with a congenital portosystemic shunt. The Veterinary Journal, 200(1), 197–199.

Konstantinidis, A. O., Patsikas, M. N., Papazoglou, L. G., & Adamama-Moraitou, K. K. (2023). Congenital portosystemic shunts in dogs and cats: Classification, pathophysiology, clinical presentation and diagnosis. Veterinary Sciences, 10(2), 160.

Kraun, M. B., Nelson, L. L., Hauptman, J. G., & Nelson, N. C. (2014). Analysis of the relationship of extrahepatic portosystemic shunt morphology with clinical variables in dogs: 53 cases (2009–2012). Journal of the American Veterinary Medical Association, 245(5), 540–549.

Krishnarao, A., & Gordon, F. D. (2020). Prognosis of hepatic encephalopathy. Clinics in Liver Disease, 24(2), 219–229.

Lawrence, Y. A., & Steiner, J. M. (2017). Laboratory evaluation of the liver. Veterinary Clinics of North America: Small Animal Practice, 47, 539–553.

Lester, C., Cooper, J., Peters, R. M., & Webster, C. R. L. (2016). Retrospective evaluation of acute liver failure in dogs (1995–2012): 49 cases. Veterinary Emergency and Critical Care Society, 26(4), 559–567.

Levitt, D. G., & Levitt, M. D. (2018). A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans. Clinical and Experimental Gastroenterology, 11, 193–215.

Lidbury, J. A., Cook, A. K., & Steiner, J. M. (2016). Hepatic encephalopathy in dogs and cats. Veterinary Emergency and Critical Care Society, 26(4), 471–487.

Lidbury, J. A., Ivanek, R., Suchodolski, J. S., & Steiner, J. M. (2015). Putative precipitating factors for hepatic encephalopathy in dogs: 118 cases (1991–2014). Journal of the American Veterinary Medical Association, 247(2), 176–183.

Lima, L. C. D., Miranda, A. S., Ferreira, R. N., Rachid, M. A., & Simões e Silva, A. C. (2019). Hepatic encephalopathy: Lessons from preclinical studies. World Journal of Hepatology, 11(2), 173–185.

Lynch, A. (2023). Hepatic encephalopathy. Small Animal Critical Care Medicine, 506–509.

Mullins, R. A., Carrera, A. E., Anderson, D. M., & Billet, J.-P. (2022). Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review. Veterinary Surgery, 51(1), 23–33.

Nardelli, S., Bellafante, D., Ridola, L., Faccioli, J., Riggio, O., & Gioia, S. (2023). Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate. Metabolic Brain Disease, 38(5), 1729–1736.

Odeh, M. (2007). Pathogenesis of hepatic encephalopathy: The tumour necrosis factor-alpha theory. European Journal of Clinical Investigation, 37(4), 291–304.

Romero-Gómez, M., Montagnese, S., & Jalan, R. (2015). Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Journal of Hepatology, 62(2), 437–447.

Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020). Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. Journal of Hepatology, 73(6), 1526–1547.

Rothuizen, J. (2009). Important clinical syndromes associated with liver disease. Veterinary Clinics of North America: Small Animal Practice, 39(3), 419–437.

Selgas, A. G., Bexfield, N., Scase, T. J., Holmes, M. A., & Watson, P. (2014). Total serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis. Journal of Veterinary Diagnostic Investigation, 26(2), 246–251.

Seller, S., Weisse, C., & Fischetti, A. J. (2022). Intrahepatic venous collaterals in dogs with congenital intrahepatic portosystemic shunts are associated with focal shunt or hepatic vein narrowing. Veterinary Radiology and Ultrasound, 63(1), 64–72.

Simonov, M., & Vlizlo, V. (2015). Some blood markers of the functional state of liver in dairy cows with clinical ketosis. Bulgarian Journal of Veterinary Medicine, 18(1). 74–82.

Swaminathan, M., Ellul, M. A., & Cross, T. J. (2018). Hepatic encephalopathy: Current challenges and future prospects. Hepatic Medicine: Evidence and Research, 10, 1–11.

Tivers, M. S., Handel, I., Gow, A. G., Lipscomb, V. J., Jalan, R., & Mellanby, R. J. (2014). Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One, 9(1), e82303.

Vallarino, N., Pil, S., Devriendt, N., Or, M., Vandermeulen, E., Serrano, G., Paepe, D., Bosmans, T., & de Rooster, H. (2020). Diagnostic value of blood variables following attenuation of congenital extrahepatic portosystemic shunt in dogs. Veterinary Record, 187(7), e48.

Vlizlo, V. V. (1999). Hepatozerebralnyj syndrom u velykoyi rohatoyi khudoby [Hepatocerebral syndrome in cattle]. Visnyk Ahrarnoyi Nauky, 8, 29–33 (in Ukrainian).

Vlizlo, V., Prystupa, O., Slivinska, L., Gutyj, B., Maksymovych, I., Shcherbatyy, A., Lychuk, M., Partyka, U., Chernushkin, B., Rusyn, V., Leno, M., & Leskiv, K. (2023). Treatment of animals with fatty liver disease using a drug based on the seeds of Silybum marianum. Regulatory Mechanisms in Biosystems, 14(3), 424–431.

Wang, A. J., Peng, A. P., Li, B. M., Gan, N., Pei, L., Zheng, X. L., Hong, J. B., Xiao, H. Y., Zhong, J. W., & Zhu, X. (2017). Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World Journal of Gastroenterology, 23(34), 6321–6329.

Webster, C. R. L. (2017). Hemostatic disorders associated with hepatobiliary disease. Veterinary Clinics of North America: Small Animal Practice, 47, 601–615.

Webster, C. R. L., Center, S. A., Cullen, J. M., Penninck, D. G., Richter, K. P., Twedt, D. C., & Watson, P. J. (2019). ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. Journal of Veterinary Internal Medicine, 33(3), 1173–1200.

Xenoulis, P. G., & Steiner, J. M. (2015). Canine hyperlipidaemia. Journal of Small Animal Practice, 56(10), 595–605.

Zelenina, O., Vlizlo, V., Kozak, M., Ostapiv, D., Samaryk, V., Dron, I., Stetsko, T., Skrypka, M., Tomchuk, V., Danchuk, O., & Levchenko, A. (2022). Antimicrobial activity of the PEGylated antibiotic enrofloxacin and its functional and structural effect on the liver in rats. Journal of Applied Pharmaceutical Science, 12(6), 68–75.